{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:11:31Z","timestamp":1794647491622,"version":"4.9.1"},"reference-count":158,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>ANCA-associated vasculitis (AAV) is comprised of three specific conditions: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). Since the publication of the last British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR) guideline for the management of adults with AAV in 2014, a plethora of randomized controlled trials, additional research and recommendations have provided novel insights into how the management of AAV can be optimized, thus improving patient quality of life. The BSR AAV Working Group (WG) reviewed published guidelines, undertook a systematic literature review and utilized expertise from specialist vasculitis centres across the UK and patient representatives to formulate a list of 26 recommendations with corresponding strength of agreement (SOA) scores. Recommendations were updated from the published 2014 BSR and BHPR guideline. The 26 recommendations encompassed five key domains: 1. Treatment for GPA and MPA; 2. Management of subglottic stenosis and ear, nose and throat (ENT) manifestations of AAV; 3. Management and treatment for EGPA; 4. Service specifications; 5. Patient education and support. These recommendations provide an update on care delivery of AAV based on current evidence and specialist opinion. In addition, we have provided research and audit recommendations to support equitable access to care and improve health outcomes. The lay summary that accompanies this abstract can be found in Supplementary Data S1, available at Rheumatology online.<\/jats:p>","DOI":"10.1093\/rheumatology\/keaf240","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T07:21:03Z","timestamp":1748848863000},"page":"4470-4494","source":"Crossref","is-referenced-by-count":50,"title":["The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-200X","authenticated-orcid":false,"given":"Kathryn","family":"Biddle","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Guy\u2019s and St Thomas' NHS Foundation Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Jade","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Wilson-Morkeh","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Imperial College Healthcare NHS Trust , London,","place":["UK"]},{"name":"National Heart and Lung Institute, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madura","family":"Adikari","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal Chesterfield NHS Foundation Trust , Chesterfield,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadwan Al","family":"Yaghchi","sequence":"additional","affiliation":[{"name":"ENT Department, Imperial College Healthcare NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Anastasa","sequence":"additional","affiliation":[{"name":"Expert by Experience , Plymouth,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Basu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Glasgow , Glasgow,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brogan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Great Ormond Street Hospital NHS Foundation Trust , London,","place":["UK"]},{"name":"Great Ormond Street Institute of Child Health, University College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Chanouzas","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, Birmingham Health Partners UK , Birmingham,","place":["UK"]},{"name":"School of Health Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham Health Partners , Birmingham,","place":["UK"]},{"name":"School of Infection, Inflammation and Immunology, College of Medicine and Health University of Birmingham, Birmingham Health Partners , Birmingham,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouvik","family":"Dass","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leeds Teaching Hospitals NHS Trust , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D'Cruz","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Guy\u2019s and St Thomas' NHS Foundation Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Martinez","family":"Del Pero","sequence":"additional","affiliation":[{"name":"ENT Department, Cambridge University Hospital , Cambridge,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmandeep","family":"Dhillon","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, New Cross Hospital, Royal Wolverhampton NHS Trust , Wolverhampton,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Ducker","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Norfolk and Norwich University Hospital , Norwich,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u00e2n","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation, University Hospital of Wales , Cardiff,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-7189","authenticated-orcid":false,"given":"Rosemary J","family":"Hollick","sequence":"additional","affiliation":[{"name":"Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen , Aberdeen,","place":["UK"]},{"name":"Department of Rheumatology, NHS Grampian , Aberdeen,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Guy\u2019s and St Thomas\u2019 NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"King","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, Birmingham Health Partners UK , Birmingham,","place":["UK"]},{"name":"School of Health Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham Health Partners , Birmingham,","place":["UK"]},{"name":"School of Infection, Inflammation and Immunology, College of Medicine and Health University of Birmingham, Birmingham Health Partners , Birmingham,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matko","family":"Marlais","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust , London,","place":["UK"]},{"name":"Department of Nephrology, West Suffolk Hospital , Bury St Edmunds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Mason","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Southampton , Southampton,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"McAdoo","sequence":"additional","affiliation":[{"name":"Immunology and Immunotherapy Department, Imperial College London , London,","place":["UK"]},{"name":"Renal and Transplant Unit, Imperial College Healthcare NHS Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devesh","family":"Mewar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Liverpool University Hospitals NHS Foundation Trust , Liverpool,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Mooney","sequence":"additional","affiliation":[{"name":"School of Health, Education, Policing and Sciences, Staffordshire University , Stafford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleana","family":"Ntatsaki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, East Suffolk and North Essex NHS Foundation Trust , Ipswich,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2884-1998","authenticated-orcid":false,"given":"Fiona","family":"Pearce","sequence":"additional","affiliation":[{"name":"Clinical Sciences Building, City Hospital Campus, University of Nottingham , Nottingham,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7554-5409","authenticated-orcid":false,"given":"Benjamin","family":"Rhodes","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospitals Birmingham NHS Trust , Birmingham,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitasha","family":"Rupani","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Hospital Southampton , Southampton,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9255-9092","authenticated-orcid":false,"given":"Alan","family":"Salama","sequence":"additional","affiliation":[{"name":"University College London Centre for Kidney and Bladder Health, Royal Free Hospital , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London , London,","place":["UK"]},{"name":"Respiratory Medicine Department, Royal Brompton and Hammersmith Hospitals , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona","family":"Smith","sequence":"additional","affiliation":[{"name":"Renal Department, University of Cambridge , Cambridge,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-9234","authenticated-orcid":false,"given":"Lorraine","family":"Harper","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, Birmingham Health Partners UK , Birmingham,","place":["UK"]},{"name":"School of Health Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham Health Partners , Birmingham,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"British Society for Rheumatology Guideline Steering Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Merrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratyasha","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rose-Parfitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devesh","family":"Mewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Compeyrot-Lacassagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Kuttikat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirushi","family":"Jayasekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coziana","family":"Ciurtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"2026072404061479200_keaf240-B1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2026072404061479200_keaf240-B2","first-page":"2308","article-title":"All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type","volume":"59","author":"Wallace","year":"2020","journal-title":"Rheumatol (United Kingdom)"},{"key":"2026072404061479200_keaf240-B3","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","article-title":"BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2026072404061479200_keaf240-B4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.41983","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis","volume":"74","author":"Suppiah","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026072404061479200_keaf240-B6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.41986","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis","volume":"74","author":"Robson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026072404061479200_keaf240-B7","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"2026072404061479200_keaf240-B8","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.kint.2023.10.008","article-title":"KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis","volume":"105","author":"Floege","year":"2024","journal-title":"Kidney Int"},{"key":"2026072404061479200_keaf240-B9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2026072404061479200_keaf240-B10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3899\/jrheum.200721","article-title":"CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update","volume":"48","author":"Mendel","year":"2021","journal-title":"J Rheumatol"},{"key":"2026072404061479200_keaf240-B12","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1016\/S2665-9913(23)00128-5","article-title":"Pan American League of Associations for Rheumatology Guidelines for the treatment of ANCA-associated vasculitis","volume":"5","author":"Magri","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2026072404061479200_keaf240-B13","doi-asserted-by":"crossref","first-page":"rkad027","DOI":"10.1093\/rap\/rkad027","article-title":"Cocaine-induced granulomatosis with polyangiitis\u2014an under-recognized condition","volume":"7","author":"Gill","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"2026072404061479200_keaf240-B14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40620-015-0208-y","article-title":"Rituximab for treatment of severe renal disease in ANCA associated vasculitis","volume":"29","author":"Geetha","year":"2016","journal-title":"J Nephrol"},{"key":"2026072404061479200_keaf240-B18","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1681\/ASN.2019111197","article-title":"Efficacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis with severe kidney disease","volume":"31","author":"Moura","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026072404061479200_keaf240-B19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/acr2.11274","article-title":"Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody\u2013Associated Vasculitis: systematic Review and Meta-Analysis","volume":"3","author":"B\u00e9nard","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"2026072404061479200_keaf240-B20","author":"NHS England","year":"2015"},{"key":"2026072404061479200_keaf240-B21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ndt\/gfx378","article-title":"Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"34","author":"McAdoo","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2026072404061479200_keaf240-B22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ekir.2017.11.004","article-title":"Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis","volume":"3","author":"Cortazar","year":"2018","journal-title":"Kidney Int Reports"},{"key":"2026072404061479200_keaf240-B23","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2026072404061479200_keaf240-B24","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1002\/art.34547","article-title":"Long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Faurschou","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2026072404061479200_keaf240-B25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2018-214245","article-title":"Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial","volume":"78","author":"Jones","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2021.609924","article-title":"The role of mycophenolate mofetil for the induction of remission in ANCA-associated vasculitis: a meta-analysis","volume":"8","author":"Xiong","year":"2021","journal-title":"Front Med"},{"key":"2026072404061479200_keaf240-B27","doi-asserted-by":"crossref","first-page":"e064604","DOI":"10.1136\/bmj-2021-064604","article-title":"The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis","volume":"376","author":"Walsh","year":"2022","journal-title":"BMJ"},{"key":"2026072404061479200_keaf240-B28","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026072404061479200_keaf240-B29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2013.131","article-title":"Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear","volume":"84","author":"Walsh","year":"2013","journal-title":"Kidney Int"},{"key":"2026072404061479200_keaf240-B30","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa0904655","article-title":"Functional status of elderly adults before and after initiation of dialysis","volume":"361","author":"Kurella Tamura","year":"2009","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B31","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/ckj\/sfac221","article-title":"PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations","volume":"16","author":"Casal Moura","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026072404061479200_keaf240-B32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/key322","article-title":"European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides\u2014the SHARE initiative","volume":"58","author":"de Graeff","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2026072404061479200_keaf240-B33","doi-asserted-by":"crossref","first-page":"152609","DOI":"10.1016\/j.semarthrit.2024.152609","article-title":"Defining cause of death in a contemporary cohort with ANCA-associated vasculitis (AAV): a comparison of electronic health record and death certificate data","volume":"70","author":"Katz","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"2026072404061479200_keaf240-B34","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1001\/jama.2021.6615","article-title":"Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a randomized clinical trial","volume":"325","author":"Furuta","year":"2021","journal-title":"JAMA"},{"key":"2026072404061479200_keaf240-B35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/ard-2023-224343","article-title":"Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study","volume":"83","author":"Furuta","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B36","doi-asserted-by":"crossref","first-page":"e050507","DOI":"10.1136\/bmjopen-2021-050507","article-title":"Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic review","volume":"12","author":"Xiao","year":"2022","journal-title":"BMJ Open"},{"key":"2026072404061479200_keaf240-B37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12882-019-1226-0","article-title":"Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study","volume":"20","author":"Chanouzas","year":"2019","journal-title":"BMC Nephrol"},{"key":"2026072404061479200_keaf240-B38","doi-asserted-by":"crossref","first-page":"e19173","DOI":"10.1097\/MD.0000000000019173","article-title":"Initial high-dose corticosteroids and renal impairment are risk factors for early severe infections in elderly patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective observational study","volume":"99","author":"Waki","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2026072404061479200_keaf240-B39","first-page":"2484","article-title":"Chanouzas D, McGregor JAG, Nightingale P et al. Effectiveness of intravenous methylprednisolone pulse in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis","volume":"63","year":"2024","journal-title":"Rheumatology (United Kingdom)"},{"key":"2026072404061479200_keaf240-B40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B41","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ekir.2023.01.039","article-title":"Renal recovery for patients with ANCA-associated vasculitis and low eGFR in the ADVOCATE trial of Avacopan","volume":"8","author":"Cortazar","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2026072404061479200_keaf240-B42","author":"NICE","year":"2022"},{"key":"2026072404061479200_keaf240-B43","author":"Scottish Medicines Consortium","year":"2023"},{"key":"2026072404061479200_keaf240-B44","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B45","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard-2022-223559","article-title":"Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial","volume":"82","author":"Smith","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B46","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/annrheumdis-2017-212768","article-title":"Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides","volume":"77","author":"Terrier","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B47","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2017-212878","article-title":"Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)","volume":"77","author":"Charles","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/ard-2023-224623","article-title":"Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials","volume":"83","author":"Delestre","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2023-224489","article-title":"Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial","volume":"83","author":"Zonozi","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B50","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B51","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/art.39450","article-title":"Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener\u2019s) or Microscopic Polyangiitis","volume":"68","author":"Pu\u00e9chal","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"2026072404061479200_keaf240-B52","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody\u2014associated vasculitis","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"key":"2026072404061479200_keaf240-B53","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/annrheumdis-2017-211123","article-title":"Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis","volume":"76","author":"Karras","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/M19-3827","article-title":"Long-term rituximab use to maintain remission of antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"173","author":"Charles","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026072404061479200_keaf240-B55","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ki.2009.218","article-title":"The clinical course of ANCA small-vessel vasculitis on chronic dialysis","volume":"76","author":"Lionaki","year":"2009","journal-title":"Kidney Int"},{"key":"2026072404061479200_keaf240-B56","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2215\/CJN.03190321","article-title":"Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis","volume":"16","author":"Kauffmann","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026072404061479200_keaf240-B57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.ajkd.2007.04.018","article-title":"Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis","volume":"50","author":"Weidanz","year":"2007","journal-title":"Am J kidney Dis Off J Natl Kidney Found"},{"key":"2026072404061479200_keaf240-B58","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/acr.20176","article-title":"Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis","volume":"62","author":"Walsh","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026072404061479200_keaf240-B59","author":"Merkel","year":"2024"},{"key":"2026072404061479200_keaf240-B60","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ndt\/gfw046","article-title":"End-stage renal disease in ANCA-associated vasculitis","volume":"32","author":"Moiseev","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2026072404061479200_keaf240-B61","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.V971258","article-title":"Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"9","author":"Allen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2026072404061479200_keaf240-B62","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/annrheumdis-2018-213452","article-title":"Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System","volume":"77","author":"Wallace","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000505660","article-title":"Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives","volume":"45","author":"Hruskova","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"2026072404061479200_keaf240-B64","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2015.03.025","article-title":"Characteristics and outcomes of granulomatosis with polyangiitis (Wegener) and microscopic polyangiitis requiring renal replacement therapy: results from the European Renal Association-European Dialysis and Transplant Association Registry","volume":"66","author":"Hruskova","year":"2015","journal-title":"Am J kidney Dis Off J Natl Kidney Found"},{"key":"2026072404061479200_keaf240-B65","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1681\/ASN.2016020126","article-title":"Kidney transplantation outcomes across GN subtypes in the United States","volume":"28","author":"O'Shaughnessy","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026072404061479200_keaf240-B66","first-page":"3219","article-title":"Renal transplantation in systemic vasculitis: when is it safe?","volume":"24","author":"Little","year":"2009","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc\u2014Eur Ren Assoc"},{"key":"2026072404061479200_keaf240-B67","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/TP.0b013e31821ab9aa","article-title":"Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience","volume":"91","author":"Geetha","year":"2011","journal-title":"Transplantation"},{"key":"2026072404061479200_keaf240-B68","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/ctr.12084","article-title":"Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation","volume":"27","author":"Marco","year":"2013","journal-title":"Clin Transplant"},{"key":"2026072404061479200_keaf240-B69","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1046\/j.1523-1755.1999.00666.x","article-title":"Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis","volume":"56","author":"Nachman","year":"1999","journal-title":"Kidney Int"},{"key":"2026072404061479200_keaf240-B70","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/rheumatology\/kez217","article-title":"Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis","volume":"58","author":"Quinn","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2026072404061479200_keaf240-B71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/01455613211036246","article-title":"Current therapeutic approaches to subglottic stenosis in patients with GPA: a systematic review","volume":"103","author":"Almuhanna","year":"2024","journal-title":"Ear Nose Throat J"},{"key":"2026072404061479200_keaf240-B72","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.21037\/jtd.2019.11.43","article-title":"Idiopathic subglottic stenosis: a review","volume":"12","author":"Aravena","year":"2020","journal-title":"J Thorac Dis"},{"key":"2026072404061479200_keaf240-B73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.55563\/clinexprheumatol\/50919f","article-title":"Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis","volume":"39 Suppl 129","author":"Monti","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"2026072404061479200_keaf240-B74","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.39786","article-title":"Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-positive granulomatosis with polyangiitis (Wegener\u2019s) is a clinically distinct subset of ANCA-associated vasculitis: a retrospective analysis of 315 patients from a german vasculitis referral cent","volume":"68","author":"Schirmer","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"2026072404061479200_keaf240-B75","doi-asserted-by":"crossref","first-page":"2473974X211054842","DOI":"10.1177\/2473974X211054842","article-title":"Serial intralesional steroid injection for subglottic stenosis: systemic side effects and impact on surgery-free interval","volume":"5","author":"Neevel","year":"2021","journal-title":"OTO open"},{"key":"2026072404061479200_keaf240-B76","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/lary.31028","article-title":"Decision-making in the treatment of idiopathic subglottic stenosis: a survey of laryngologists","volume":"134","author":"Razura","year":"2024","journal-title":"Laryngoscope"},{"key":"2026072404061479200_keaf240-B77","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.semarthrit.2018.05.005","article-title":"Frequency, treatment, evolution, and factors associated with the presence of tracheobronchial stenoses in granulomatosis with polyangiitis. Retrospective analysis of a case series from a single respiratory referral center","volume":"48","author":"Marroqu\u00edn-Fabi\u00e1n","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2026072404061479200_keaf240-B78","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/rheumatology\/kev129","article-title":"Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience","volume":"54","author":"Terrier","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2026072404061479200_keaf240-B79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.chest.2021.07.037","article-title":"Presentation, diagnosis, and management of subglottic and tracheal stenosis during systemic inflammatory diseases","volume":"161","author":"Catano","year":"2022","journal-title":"Chest"},{"key":"2026072404061479200_keaf240-B80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/03009742.2020.1777324","article-title":"Sirolimus use in patients with subglottic stenosis in the context of granulomatosis with polyangiitis (GPA), suspected GPA, and immunoglobulin G4-related disease","volume":"50","author":"Poo","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"2026072404061479200_keaf240-B81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejim.2023.05.006","article-title":"Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: analysis of a single-centre cohort","volume":"114","author":"Moroni","year":"2023","journal-title":"Eur J Intern Med"},{"key":"2026072404061479200_keaf240-B82","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1017\/S0022215106005032","article-title":"Patterns of presentation and diagnosis of patients with Wegener\u2019s granulomatosis: ENT aspects","volume":"121","author":"Srouji","year":"2007","journal-title":"J Laryngol Otol"},{"key":"2026072404061479200_keaf240-B83","first-page":"e89","article-title":"Health-related quality of life in patients with ANCA-associated vasculitis and sinonasal involvement: a single-center cross-sectional study","volume":"28","author":"Cazzador","year":"2022","journal-title":"J Clin Rheumatol Pract Reports Rheum Musculoskelet Dis"},{"key":"2026072404061479200_keaf240-B84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/qjmed\/hcx194","article-title":"Can granulomatosis with polyangiitis be diagnosed earlier in primary care? A case-control study","volume":"111","author":"Pearce","year":"2018","journal-title":"QJM Mon J Assoc Physicians"},{"key":"2026072404061479200_keaf240-B85","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/rheumatology\/keab719","article-title":"Localized versus systemic granulomatosis with polyangiitis: data from the French Vasculitis Study Group Registry","volume":"61","author":"Iudici","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026072404061479200_keaf240-B86","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody\u2014Associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026072404061479200_keaf240-B87","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/rheumatology\/keaa667","article-title":"Prevalence and risk factors of relapse in patients with ANCA-associated vasculitis receiving cyclophosphamide induction: a systematic review and meta-analysis of large observational studies","volume":"60","author":"He","year":"2021","journal-title":"Rheumatology (United Kingdom)"},{"key":"2026072404061479200_keaf240-B88","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/rheumatology\/keaa541","article-title":"Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models","volume":"60","author":"McClure","year":"2021","journal-title":"Rheumatology (United Kingdom)"},{"key":"2026072404061479200_keaf240-B89","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13075-022-02885-9","article-title":"Cluster analysis of patients with granulomatosis with polyangiitis (GPA) based on clinical presentation symptoms: a UK population-based cohort study","volume":"24","author":"Thayakaran","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2026072404061479200_keaf240-B90","doi-asserted-by":"crossref","first-page":"103485","DOI":"10.1016\/j.amjoto.2022.103485","article-title":"Added value of Joint ENT-Rheumatology clinic in the management of ANCA-associated vasculitis: one year\u2019s experience","volume":"43","author":"Stavrakas","year":"2022","journal-title":"Am J Otolaryngol"},{"key":"2026072404061479200_keaf240-B91","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez063.016","article-title":"292. Utility of a one-stop joint ENT-vasculitis clinic in the managment of relapsing ANCA-associated vasculitis","volume":"58","author":"O\u2019Malley","year":"2019","journal-title":"Rheumatology"},{"key":"2026072404061479200_keaf240-B92","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4193\/Rhino13.112","article-title":"Cocaine induced midline destructive lesions","volume":"52","author":"Trimarchi","year":"2014","journal-title":"Rhinology"},{"key":"2026072404061479200_keaf240-B93","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2215\/CJN.03440411","article-title":"Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease","volume":"6","author":"McGrath","year":"2011","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"2026072404061479200_keaf240-B94","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/20009666.2018.1536242","article-title":"Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis","volume":"8","author":"Jin","year":"2018","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2026072404061479200_keaf240-B95","author":"Department of Health","year":"2021"},{"key":"2026072404061479200_keaf240-B96","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00000478-199006000-00006","article-title":"Interpretation of head and neck biopsies in Wegener\u2019s granulomatosis. A pathologic study of 126 biopsies in 70 patients","volume":"14","author":"Devaney","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"2026072404061479200_keaf240-B97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0463.1990.tb05705.x","article-title":"Histopathological findings in biopsies from patients with Wegener\u2019s granulomatosis","volume":"19","author":"Rasmussen","year":"1990","journal-title":"APMIS Suppl"},{"key":"2026072404061479200_keaf240-B98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0046-8177(91)90030-S","article-title":"Diagnostic usefulness of nasal biopsy in Wegener\u2019s granulomatosis","volume":"22","author":"Del Buono","year":"1991","journal-title":"Hum Pathol"},{"key":"2026072404061479200_keaf240-B99","first-page":"7","article-title":"International Rhinology Journal European Position Paper on Rhinosinusitis and Nasal Polyps","volume":"1","author":"Fokkens","year":"2020","journal-title":"Epos 2020"},{"key":"2026072404061479200_keaf240-B100","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/rheumatology\/kex001","article-title":"Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate","volume":"56","author":"Salmela","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026072404061479200_keaf240-B101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group","volume":"335","author":"Stegeman","year":"1996","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B102","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1093\/rheumatology\/keab267","article-title":"The role of trimethoprim\/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis","volume":"60","author":"Monti","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026072404061479200_keaf240-B103","first-page":"CD003232","article-title":"Interventions for renal vasculitis in adults","volume":"1","author":"Walters","year":"2020","journal-title":"Cochrane database Syst Rev"},{"key":"2026072404061479200_keaf240-B104","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/2050312120936731","article-title":"The role of surgery in antineutrophil cytoplasmic antibody\u2013associated vasculitides affecting the nose and sinuses: a systematic review","volume":"8","author":"Pendolino","year":"2020","journal-title":"SAGE Open Med"},{"key":"2026072404061479200_keaf240-B105","doi-asserted-by":"crossref","first-page":"e195\u2013203","DOI":"10.1016\/j.bjps.2014.03.029","article-title":"Avoiding pitfalls in open augmentation rhinoplasty with autologous L-shaped costal cartilage strut grafts for saddle nose collapse due to autoimmune disease: the Cambridge experience","volume":"67","author":"Qian","year":"2014","journal-title":"J Plast Reconstr Aesthetic Surg"},{"key":"2026072404061479200_keaf240-B106","first-page":"61","article-title":"Nasal reconstruction in granulomatosis with polyangiitis: a two decade review","volume":"25","author":"Gantous","year":"2023","journal-title":"Facial Plast Surg Aesthetic Med"},{"key":"2026072404061479200_keaf240-B107","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5604\/01.3001.0011.7258","article-title":"Indications and long-term outcomes of open augmentation rhinoplasty with autogenous L-shaped costal cartilage strut grafts\u2014a single plastic surgeon\u2019s experience","volume":"72","author":"Leach","year":"2018","journal-title":"Otolaryngol Pol"},{"key":"2026072404061479200_keaf240-B108","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur Respir J"},{"key":"2026072404061479200_keaf240-B109","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/cea.13889","article-title":"The causes of a peripheral blood eosinophilia in a secondary care setting","volume":"51","author":"Wardlaw","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"2026072404061479200_keaf240-B110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art","volume":"68","author":"Vaglio","year":"2013","journal-title":"Allergy"},{"key":"2026072404061479200_keaf240-B111","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"2026072404061479200_keaf240-B112","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/rheumatology\/keab514","article-title":"Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss)","volume":"61","author":"Sartorelli","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026072404061479200_keaf240-B113","article-title":"Rituximab versus conventional therapeutic strategy for remission induction in eosinophilic granulomatosis with polyangiitis: a double-blind, randomized, controlled trial","author":"Terrier","year":"2024","journal-title":"ACR Meeting Abstracts"},{"key":"2026072404061479200_keaf240-B114","doi-asserted-by":"crossref","first-page":"e000905","DOI":"10.1136\/rmdopen-2019-000905","article-title":"Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis","volume":"5","author":"Teixeira","year":"2019","journal-title":"RMD Open"},{"key":"2026072404061479200_keaf240-B115","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B116","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"2026072404061479200_keaf240-B117","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.41943","article-title":"Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study","volume":"74","author":"Bettiol","year":"2022","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"2026072404061479200_keaf240-B118","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/art.40205","article-title":"Adding azathioprine to remission-induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (churg-strauss), microscopic polyangiitis, or polyarteritis nodosa without poor prognosis factors: a randomized, controlled trial","volume":"69","author":"Pu\u00e9chal","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2026072404061479200_keaf240-B119","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00296-021-04961-w","article-title":"A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis","volume":"41","author":"Philobos","year":"2021","journal-title":"Rheumatol Int"},{"key":"2026072404061479200_keaf240-B120","first-page":"S52","article-title":"Churg Strauss syndrome\u2014Successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment","volume":"22","author":"Metzler","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"2026072404061479200_keaf240-B121","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2017-211897","article-title":"Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis","volume":"77","author":"Emmi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B122","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10067-019-04891-w","article-title":"Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab","volume":"39","author":"Casal Moura","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2026072404061479200_keaf240-B123","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2665-9913(24)00082-1","article-title":"Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study","volume":"6","author":"Hollick","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2026072404061479200_keaf240-B124","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/rheumatology\/keae163.223","article-title":"P184 Geographical variations in delivery of intravenous treatments for ANCA-associated vasculitis","volume":"63","author":"James","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026072404061479200_keaf240-B125","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/rheumatology\/keae336","article-title":"Performance of clinical and histological prognostic scores for kidney survival in ANCA-associated vasculitis","volume":"64","author":"Sandino-Berm\u00fadez","year":"2025","journal-title":"Rheumatology"},{"key":"2026072404061479200_keaf240-B126","author":"Department of Health and Social Care","year":"2021"},{"key":"2026072404061479200_keaf240-B127","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): Monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026072404061479200_keaf240-B128","first-page":"1","author":"NICE","year":"2016"},{"key":"2026072404061479200_keaf240-B129","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.athoracsur.2015.05.056","article-title":"The effects of a multidisciplinary care conference on the quality and cost of care for lung cancer patients","volume":"100","author":"Freeman","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2026072404061479200_keaf240-B130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/JMDH.S117945","article-title":"Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: An overview and synthesis of the available literature","volume":"11","author":"Soukup","year":"2018","journal-title":"J Multidiscip Healthc"},{"key":"2026072404061479200_keaf240-B131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjoq-2022-002130","article-title":"Facilitators and barriers to conducting an efficient, competent and high-quality oncological multidisciplinary team meeting","volume":"12","author":"Walraven","year":"2023","journal-title":"BMJ Open Qual"},{"key":"2026072404061479200_keaf240-B132","first-page":"1","author":"NHS England"},{"key":"2026072404061479200_keaf240-B133","author":"Kay","year":"2021"},{"key":"2026072404061479200_keaf240-B134","author":"NHS Scotland"},{"key":"2026072404061479200_keaf240-B135","author":"NHS Wales"},{"key":"2026072404061479200_keaf240-B136","author":"Department of Health and Social Care","year":"2024"},{"key":"2026072404061479200_keaf240-B137","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/acr.23161","article-title":"Disease outcomes and care fragmentation among patients with systemic lupus erthematosus","volume":"69","author":"Walunas","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2026072404061479200_keaf240-B138","doi-asserted-by":"crossref","first-page":"e2105","DOI":"10.1136\/bmj.e2105","article-title":"Impact of managed clinical networks on NHS specialist neonatal services in England: population based study","volume":"344","author":"Gale","year":"2012","journal-title":"BMJ"},{"key":"2026072404061479200_keaf240-B139","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5694\/mja13.10645","article-title":"Impact of a regionalised clinical cardiac support network on mortality among rural patients with myocardial infarction","volume":"200","author":"Tideman","year":"2014","journal-title":"Med J Aust"},{"key":"2026072404061479200_keaf240-B140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0036933014529241","article-title":"The impact of a managed clinical network on referral patterns of sarcoma patients in grampian","volume":"59","author":"Mccullough","year":"2014","journal-title":"Scott Med J"},{"key":"2026072404061479200_keaf240-B141","first-page":"e10","article-title":"A managed clinical network for cardiac services: set-up, operation and impact on patient care","volume":"5","author":"Stc Hamilton","year":"2005","journal-title":"Int J Integr Care"},{"key":"2026072404061479200_keaf240-B142","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/qshc.2007.023119","article-title":"Do managed clinical networks improve quality of diabetes care? Evidence from a retrospective mixed methods evaluation","volume":"18","author":"Greene","year":"2009","journal-title":"Qual Saf Heal Care"},{"key":"2026072404061479200_keaf240-B143","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.bjc.6600057","article-title":"A controlled \u201cbefore-after\u201d study: impact of a clinical guidelines programme and regional cancer network organization on medical practice","volume":"86","author":"Ray-Coquard","year":"2002","journal-title":"Br J Cancer"},{"key":"2026072404061479200_keaf240-B144","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0272-6386(99)70013-2","article-title":"Can dialysis therapy be improved? A report from the ESRD core indicators project","volume":"34","author":"McClellan","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2026072404061479200_keaf240-B145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3389\/fneur.2020.00573","article-title":"Design and operation of the Lombardy Parkinson\u2019s disease network","volume":"11","author":"Albanese","year":"2020","journal-title":"Front Neurol"},{"key":"2026072404061479200_keaf240-B146","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1748-5908-7-108","article-title":"Net benefits: assessing the effectiveness of clinical networks in Australia through qualitative methods","volume":"7","author":"Cunningham","year":"2012","journal-title":"Implement Sci"},{"key":"2026072404061479200_keaf240-B147","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12904-021-00712-7","article-title":"Development of a managed clinical network for children\u2019s palliative care\u2014a qualitative evaluation","volume":"20","author":"Papworth","year":"2021","journal-title":"BMC Palliat Care"},{"key":"2026072404061479200_keaf240-B148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/QFGT2379","article-title":"Centralisation of specialist cancer surgery services in two areas of England: the RESPECT-21 mixed-methods evaluation","volume":"11","author":"Fulop","year":"2023","journal-title":"Heal Soc Care Deliv Res"},{"key":"2026072404061479200_keaf240-B149","author":"Feinmann","year":"2018"},{"key":"2026072404061479200_keaf240-B150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12913-020-4991-3","article-title":"Defining patient communication needs during hospitalization to improve patient experience and health literacy","volume":"20","author":"Marca-Frances","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2026072404061479200_keaf240-B151","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/jorc.12412","article-title":"Patients with ANCA-associated vasculitis\u2019 experiences of informational needs: a qualitative interview study","volume":"48","author":"Thorborg","year":"2022","journal-title":"J Ren Care"},{"key":"2026072404061479200_keaf240-B152","doi-asserted-by":"crossref","first-page":"rkac062","DOI":"10.1093\/rap\/rkac062","article-title":"Exploring the educational needs of patients with systemic vasculitis using the educational needs assessment tool","volume":"6","author":"Brolin","year":"2022","journal-title":"Rheumatol Adv Pract"},{"key":"2026072404061479200_keaf240-B153","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/hex.12515","article-title":"Communication and patient participation influencing patient recall of treatment discussions","volume":"20","author":"Richard","year":"2017","journal-title":"Heal Expect"},{"key":"2026072404061479200_keaf240-B154","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/03610739608254020","article-title":"Remembering what the doctor said: organization and adults\u2019 memory for medical information","volume":"22","author":"McGuire","year":"1996","journal-title":"Exp Aging Res"},{"key":"2026072404061479200_keaf240-B155","doi-asserted-by":"crossref","first-page":"rkab075","DOI":"10.1093\/rap\/rkab075","article-title":"Addressing the transition to a chronic condition: Exploring independent adoption of self-management by patients with ANCA-associated vasculitis","volume":"5","author":"Litchfield","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"2026072404061479200_keaf240-B156","author":"NICE","year":"2021"},{"key":"2026072404061479200_keaf240-B157","author":"Scottish Systemic Vasculitis Network"},{"key":"2026072404061479200_keaf240-B158","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/jep.13118","article-title":"Patients admitted to more research-active hospitals have more confidence in staff and are better informed about their condition and medication: results from a retrospective cross-sectional study","volume":"26","author":"Jonker","year":"2020","journal-title":"J Eval Clin Pract"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf240\/63467336\/keaf240.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/8\/4470\/63467336\/keaf240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/8\/4470\/63467336\/keaf240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:06:38Z","timestamp":1784880398000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/8\/4470\/8160140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":158,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf240","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,6,12]]}}}